" .... [William Donald] Kelley was so unique in terms of the successes he had, the genius. That’s a one-in-a-generation kind of brilliance. That genius is such a rare thing; [Max] Gerson was a genius. Kelley was an absolute genius. That was the problem. He was so far ahead of his time. No one in his field, even the alternative people, could understand what he was talking about. There aren’t that many people like him..... "
In the 80's, Robert A. Good, then director of Sloan Kettering Cancer Research, advised a student of his, Nicholas Gonzalez, how to go about extracting data from the papers of William Donald Kelley and his alternative cure for cancer. Good gave him suggestions on how to extract the data, with pointers on the specific types of cancers and the patients who had followed Kelley's methods and ended up exceeding orthodoxy's expected surivival rates for the cancers the had. Gonzalez spent several years "extracting", by which time, strangely enough, Good was no longer in the same position of power. Nonetheless, the findings from this extraction, which highlighted the considerable success of Kelley's alternative treatment for cancer, are out there for anyone who can be troubled to find & read them. This extraction reviewed 1300 select patients who'd followed Kelley's method. Ever hear of them? I didn't think so. Why not? His alernative method was covered in the March 1996 issue of the Townsend Letter for Doctors and Patients. Here is a quote from that.
" RC: The way Dr. Kelley started-- correct me if I’m wrong-- was when he found out he had pancreatic cancer he walked into a health food store and bought pancreatic enzymes. The whole thing began by chance.
NG: That's right. It was purely by chance. He had a lot of digestive problems, as patients with pancreatic cancer will. In an attempt to help his digestive problems, he started taking huge doses of pancreatic enzymes and immediately felt a change in his tumor. That's how it started.
RC: There are many facets to the therapy that you do, but pancreatic enzymes are-- you believe-- the most powerful anticancer substances available. Why are they so anti-cancer?
NG: It’s the way the body is designed. In orthodox and even unorthodox physiology, we tend to think that the enzymes serve one function: to help to digest food. Indeed they do that. But Kelley-- as did many researchers before him and since-- believed that the enzymes are a primary defense against cancer, and are far more important than the immune system in terms of controlling the development and growth of cancer. So we believe that is one of their designated functions in the human body.
RC: Critics of this will say, "Pancreatic enzymes released into the digestive tract are molecules way too big to get into the bloodstream."
NG: In the 1940s, scientists documented that they do in fact get absorbed. There is a wonderful study from 1976 in Science magazine, one of the ultimate scientific journals, where a professor at Cornell did a study with rabbits and mice and found that the pancreatic enzymes are absorbed through the intestinal tract, complete and active, and are not destroyed in the gut.
RC: Are there any studies on pancreatic enzymes' anti-cancer activity?
NG: Yes. There is a wonderful study from 1965 where a doctor used them in animal models and a doctor found they had an extraordinary, powerful anti-cancer effect.
RC: Now these are inexpensive substances, aren't they, compared to pharmaceuticals?
RC: Why hasn't there been a greater interest in pancreatic enzymes? I know they were studied for nearly a hundred years. Is it because they were overshadowed by the work of Madam Curie, and the belief her work generated that radiation would cure all cancer? Or is it because pancreatic enzymes are unpatentable?
NG: Because of FDA regulations, pancreatic enzymes fall in the category of a natural substance. Therefore, there is no impetus for a drug company to spend hundreds of millions of dollars in researching pancreatic enzymes. They cannot patent what they might find. There is also the psychological resistance to look at natural substances in the orthodox research community, although that is starting to change...."